Overview

Study on Therapy of Non-invasive Prolactinoma

Status:
Recruiting

Trial end date:
2025-12-31

Target enrollment:

Participant gender:

Summary

the study aim to investigate the endocrine remission rate of non-invasive prolactinoma between transsphenoidal surgery treatment and Dopamine agonist treatment.

Phase:

N/A

Details

Lead Sponsor:

First Affiliated Hospital, Sun Yat-Sen University

Treatments:

Dopamine
Dopamine Agents
Dopamine Agonists